{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:41:37Z","timestamp":1778661697839,"version":"3.51.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1086\/314062","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:58:36Z","timestamp":1027709916000},"page":"S109-S114","source":"Crossref","is-referenced-by-count":17,"title":["Immunostimulation in the Urinary Bladder by Local Application of Nocardia rubra Cell-Wall Skeletons (Rubratin) and Bacillus Calmette-Gu\u00e9rin as Therapy for Superficial Bladder Cancer: A Comparative Study"],"prefix":"10.1093","volume":"31","author":[{"given":"Elizabeth C.","family":"de Boer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo M.","family":"De Reijke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter C. N.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Heinz","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis H. J.","family":"Schamhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2000,9]]},"reference":[{"key":"key\n\t\t\t\t20171014011019_R1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-5347(17)45604-7","article-title":"Long-term effect of intravesical bacillus Calmette-Gu\u00e9rin on flat carcinoma in situ of the bladder","volume":"135","author":"Herr","year":"1986","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014011019_R2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-4295(92)90202-8","article-title":"Current perspectives and treatment of superficial bladder cancer","volume":"39","author":"Lamm","year":"1992","journal-title":"Urology"},{"key":"key\n\t\t\t\t20171014011019_R3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Gu\u00e9rin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014011019_R4","first-page":"4038","article-title":"Antitumor effect of Nocardia rubra cell wall skeleton on syngeneically transplanted P388 tumors","volume":"51","author":"Izumi","year":"1991","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171014011019_R5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF00199127","article-title":"Mechanisms of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activity factor production by lymphocytes","volume":"22","author":"Masuno","year":"1986","journal-title":"Cancer Immunol Immunother"},{"key":"key\n\t\t\t\t20171014011019_R6","first-page":"5261","article-title":"Synergistic effect of Nocardia rubra cell wall skeleton and recombinant interleukin-2 for in vivo induction of lymphokine-activated killer cells","volume":"51","author":"Miyazaki","year":"1991","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171014011019_R7","first-page":"279","article-title":"Immunotherapy of cancer with cell-wall-skeleton of Nocardia rubra","volume-title":"Immunobiology and immunotherapy of cancer","author":"Yamamura","year":"1979"},{"key":"key\n\t\t\t\t20171014011019_R8","first-page":"5575","article-title":"Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer","volume":"43","author":"Yamamura","year":"1983","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171014011019_R9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000417996","article-title":"Immunotherapy with Nocardia rubra cell wall skeleton (Rubratin)","volume-title":"Contributions to oncology. Vol. 37: New drugs in oncology","author":"Aulenbacher","year":"1989"},{"key":"key\n\t\t\t\t20171014011019_R10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000417997","article-title":"Immunomodulating activity of Rubratin: results of a phase II trial in advanced lung cancer","volume-title":"Contributions to oncology. Vol. 37: New drugs in oncology","author":"Drings","year":"1989"},{"key":"key\n\t\t\t\t20171014011019_R11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF00199130","article-title":"Randomized controlled study of postoperative adjuvant immunochemotherapy with Nocardia rubra cell wall skeleton (RUBRATIN) and Tegafur for gastric carcinoma","volume":"22","author":"Koyama","year":"1986","journal-title":"Cancer Immunol Immunother"},{"key":"key\n\t\t\t\t20171014011019_R12","first-page":"3001","article-title":"Randomly controlled study of chemotherapy versus chemoimmunotherapy in postoperative gastric cancer patients","volume":"43","author":"Ochiai","year":"1983","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171014011019_R13","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/1097-0142(19860415)57:8<1483::AID-CNCR2820570808>3.0.CO;2-7","article-title":"Randomized controlled study of chemoimmunotherapy of acute myelogenous leukemia (AML) in adults with Nocardia rubra cell wall skeleton and irradiated allogeneic AML cells","volume":"57","author":"Ohno","year":"1986","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20171014011019_R14","first-page":"71","article-title":"Nocardia rubra cell wall skeleton in the therapy of animal and human cancer","volume-title":"Augmenting agents in cancer therapy","author":"Yamamura","year":"1981"},{"key":"key\n\t\t\t\t20171014011019_R15","first-page":"1413","article-title":"Randomly controlled study of chemotherapy versus chemoimmunotherapy in postoperative lung cancer patients","volume":"45","author":"Yasumoto","year":"1985","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171014011019_R16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2176\/nmc.24.19","article-title":"Multimodality treatment of malignant glioma","volume":"24","author":"Yoshida","year":"1984","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"key\n\t\t\t\t20171014011019_R17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01741551","article-title":"Induction of urinary IL-1, IL-2, IL-6, and TNF during intravesical immunotherapy with BCG in superficial bladder cancer","volume":"34","author":"De Boer","year":"1992","journal-title":"Cancer Immunol Immunother"},{"key":"key\n\t\t\t\t20171014011019_R18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01741603","article-title":"Presence of activated lymphocytes in the urine of patients with superficial bladder cancer after intravesical immunotherapy with bacillus Calmette-Gu\u00e9rin","volume":"33","author":"De Boer","year":"1991","journal-title":"Cancer Immunol Immunother"},{"key":"key\n\t\t\t\t20171014011019_R19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00299717","article-title":"BCG treatment and the importance of an inflammatory response","volume":"20","author":"Schamhart","year":"1992","journal-title":"Urol Res"},{"key":"key\n\t\t\t\t20171014011019_R20","first-page":"1","article-title":"The natural history and the prognosis of treated superficial bladder cancer","volume":"378","author":"Kurth","year":"1992","journal-title":"Prog Clin Biol Res"},{"key":"key\n\t\t\t\t20171014011019_R21","first-page":"214","article-title":"Intravesical treatment of superficial bladder cancer with Rubratin and KLH\u2014comparison of the immune profiles [abstract 192]","volume-title":"Abstracts of 22d Congress Societ\u00e9 Internationale d'Urologie (SIU) (Seville, Spain)","author":"Jurincic","year":"1991"},{"key":"key\n\t\t\t\t20171014011019_R22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-5347(17)46976-X","article-title":"Intravesical BCG therapy for superficial bladder cancer: effect of BCG viability on treatment results","volume":"134","author":"Kelley","year":"1985","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014011019_R23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1464-410X.1991.tb15072.x","article-title":"Adjuvant topical chemotherapy versus immunotherapy in primary superficial transitional cell carcinoma of the bladder","volume":"67","author":"Flamm","year":"1991","journal-title":"Br J Urol"},{"key":"key\n\t\t\t\t20171014011019_R24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0022-5347(17)39547-2","article-title":"A randomized controlled study of intravesical \u03b1-2b-interferon in carcinoma in situ of the bladder","volume":"144","author":"Glashan","year":"1990","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014011019_R25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0022-5347(17)42610-3","article-title":"Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study","volume":"139","author":"Jurincic","year":"1988","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014011019_R26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00261051","article-title":"Immunological aspects of intravesical administration of bacillus Calmette-Gu\u00e9rin (BCG) in the guinea pig","volume":"17","author":"Van der Meijden","year":"1989","journal-title":"Urol Res"},{"key":"key\n\t\t\t\t20171014011019_R27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S0022-5347(01)65748-3","article-title":"Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Gu\u00e9rin (BCG) therapy in orthotopic murine bladder cancer","volume":"156","author":"Chin","year":"1996","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014011019_R28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/IAI.59.1.421-427.1991","article-title":"Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria","volume":"59","author":"Hedges","year":"1991","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171014011019_R29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0090-1229(86)90043-7","article-title":"Interleukin-2 production during intravesical bacillus Calmette-Gu\u00e9rin therapy for bladder cancer","volume":"40","author":"Ratliff","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"key":"key\n\t\t\t\t20171014011019_R30","first-page":"231","article-title":"Cytokine production by the bladder carcinoma cell line 5637: rapid analysis of mRNA expression levels using a cDNA-PCR procedure","volume":"10","author":"Kaashoek","year":"1991","journal-title":"Lymphokine Cytokine Res"},{"key":"key\n\t\t\t\t20171014011019_R31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/eji.1830160825","article-title":"B cell growth and differentiation by supernatants of transformed epithelial cell lines","volume":"16","author":"Rawle","year":"1986","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20171014011019_R32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF00296835","article-title":"Cytokine production by the human bladder carcinoma cell line T24 in the presence of bacillus Calmette-Gu\u00e9rin (BCG)","volume":"21","author":"De Reijke","year":"1993","journal-title":"Urol Res"},{"key":"key\n\t\t\t\t20171014011019_R33","first-page":"4286","article-title":"Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells","volume":"52","author":"Lattime","year":"1992","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20171014011019_R34","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-5347(17)37668-1","article-title":"Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall","volume":"147","author":"Prescott","year":"1992","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014011019_R35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-5347(17)43909-7","article-title":"Requirement of a thymus dependent immune response for BCG-mediated antitumor activity","volume":"137","author":"Ratliff","year":"1987","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20171014011019_R36","first-page":"107","article-title":"Mechanisms of action of intravesical BCG for bladder cancer","volume":"310","author":"Ratliff","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"key\n\t\t\t\t20171014011019_R37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-5347(01)66424-3","article-title":"Urinary cytokines during intravesical bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer: processing, stability and prognostic value","volume":"155","author":"De Reijke","year":"1996","journal-title":"J Urol"},{"issue":"Suppl","key":"key\n\t\t\t\t20171014011019_R38","first-page":"S42","article-title":"Correlation between increased T-lymphocyte CD4\/CD8-ratio and T-cell activation (FACS analysis) and cytokine induction during intravesical BCG therapy","volume":"2","author":"De Boer","year":"1993","journal-title":"Urologe A"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/31\/Supplement_3\/S109\/20903232\/31-Supplement_3-S109.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T08:52:59Z","timestamp":1621241579000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/31\/Supplement_3\/S109\/330902\/Immunostimulation-in-the-Urinary-Bladder-by-Local"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,1]]},"references-count":38,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2000,9]]},"published-print":{"date-parts":[[2000,9,1]]}},"URL":"https:\/\/doi.org\/10.1086\/314062","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2000,9]]},"published":{"date-parts":[[2000,9,1]]}}}